Endocannabinoid/Endocannabinoid-like
Products Related to Endocannabinoid/Endocannabinoid-like(141)
- GC41650(±)14(15)-EET EthanolamidePurity: >95.00%
Arachidonyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC41655(±)19(20)-EDP EthanolamideCAS: 2123485-34-5Purity: >98.00%
(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively).
- GC41659(±)-2-Methyl Arachidonoyl-2'-FluoroethylamideCAS: 166100-39-6Purity: >95.00%
(±)-2-Methyl arachidonoyl-2'-fluoroethylamide (2-Methyl-2'-fluoro AEA) is an analog of anandamide (AEA) in which the alcohol of the ethanolamide group has been removed and replaced with a fluorine atom.
- GC41662(±)5(6)-EET EthanolamidePurity: >95.00%
Arachidonyl ethanolamide is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC41665(±)8(9)-EET EthanolamidePurity: >98.00%
Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC41705(R)-(-)-Docosahexaenyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41706(R)-(-)-Eicosapentaenyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41708(R)-(-)-Linoleyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41709(R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-PropylamideCAS: 1282618-08-9Purity: >98.00%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41710(R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41711(R)-(+)-Linoleyl-1'-Hydroxy-2'-PropylamideCAS: 220556-74-1Purity: >98.00%
N-Acyl ethanolamines have diverse biological actions that are strongly affected by the associated acyl group.
- GC41724(S)-(-)-Docosahexaenyl-1'-Hydroxy-2'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41725(S)-(-)-Eicosapentaenyl-1'-Hydroxy-2'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41726(S)-(-)-Linoleyl-1'-Hydroxy-2'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41728(S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41729(S)-(+)-Eicosapentaenyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC41731(S)-(+)-Linoleyl-2'-Hydroxy-1'-PropylamidePurity: >98%
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group.
- GC4192515(S)-HETE EthanolamideCAS: 161744-53-2Purity: >98.00%
Arachidonoyl ethanolamide was the first endogenous cannabinoid (CB) to be isolated and characterized as an agonist acting on the same receptors (CB1 and CB2) as THC.
- GC419861-Arachidonoyl Lysophosphatidic Acid (ammonium salt)CAS: 799268-65-8Purity: >95.00%
1-Arachidonoyl lysophosphatidic acid is a phospholipid containing arachidonic acid at the sn-1 position.
- GC4208320-HETE EthanolamideCAS: 942069-11-6Purity: >98.00%
Arachidonoyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors.
- GC4208520-hydroxy N-Arachidonoyl TaurinePurity: >95.00%
Arachidonic acid is metabolized by cytochrome P450 (CYP450) 4A ω-hydroxylase to 20-HETE, which acts as a vasoconstrictor in the kidney and brain.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC41650 | (±)14(15)-EET Ethanolamide | - | >95.00% | |
Arachidonyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC41655 | (±)19(20)-EDP Ethanolamide | 2123485-34-5 | >98.00% | |
(±)19(20)-EDP ethanolamide is an ω-3 endocannabinoid epoxide and cannabinoid (CB) receptor agonist (EC50s = 108 and 280 nM for CB1 and CB2, respectively). | ||||
| GC41659 | (±)-2-Methyl Arachidonoyl-2'-Fluoroethylamide | 166100-39-6 | >95.00% | |
(±)-2-Methyl arachidonoyl-2'-fluoroethylamide (2-Methyl-2'-fluoro AEA) is an analog of anandamide (AEA) in which the alcohol of the ethanolamide group has been removed and replaced with a fluorine atom. | ||||
| GC41662 | (±)5(6)-EET Ethanolamide | - | >95.00% | |
Arachidonyl ethanolamide is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC41665 | (±)8(9)-EET Ethanolamide | - | >98.00% | |
Arachidonoyl ethanolamide (AEA; anandamide) is an endogenous lipid neurotransmitter with cannabinergic activity, binding to both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC41705 | (R)-(-)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41706 | (R)-(-)-Eicosapentaenyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41708 | (R)-(-)-Linoleyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41709 | (R)-(+)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide | 1282618-08-9 | >98.00% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41710 | (R)-(+)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41711 | (R)-(+)-Linoleyl-1'-Hydroxy-2'-Propylamide | 220556-74-1 | >98.00% | |
N-Acyl ethanolamines have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41718 | (R)-KT109 | 2055172-60-4 | >98.00% | |
(R)-KT109 is the (R) isomer of the diacylglycerol lipase β (DAGLβ) inhibitor KT109. | ||||
| GC41724 | (S)-(-)-Docosahexaenyl-1'-Hydroxy-2'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41725 | (S)-(-)-Eicosapentaenyl-1'-Hydroxy-2'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41726 | (S)-(-)-Linoleyl-1'-Hydroxy-2'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41728 | (S)-(+)-Docosahexaenyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41729 | (S)-(+)-Eicosapentaenyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41731 | (S)-(+)-Linoleyl-2'-Hydroxy-1'-Propylamide | - | >98% | |
N-Acyl ethanolamines (NAEs) have diverse biological actions that are strongly affected by the associated acyl group. | ||||
| GC41738 | (S)-KT109 | 2055172-61-5 | >98.00% | |
(S)-KT109 is the (S) isomer of the diacylglycerol lipase β (DAGLβ) inhibitor KT109. | ||||
| GC41910 | 13-Docosenamide | 112-84-5 | >98.00% | |
13-Docosenamide is the amide of docosenoic acid. | ||||
| GC41925 | 15(S)-HETE Ethanolamide | 161744-53-2 | >98.00% | |
Arachidonoyl ethanolamide was the first endogenous cannabinoid (CB) to be isolated and characterized as an agonist acting on the same receptors (CB1 and CB2) as THC. | ||||
| GC41986 | 1-Arachidonoyl Lysophosphatidic Acid (ammonium salt) | 799268-65-8 | >95.00% | |
1-Arachidonoyl lysophosphatidic acid is a phospholipid containing arachidonic acid at the sn-1 position. | ||||
| GC42083 | 20-HETE Ethanolamide | 942069-11-6 | >98.00% | |
Arachidonoyl ethanolamide (AEA) is an endogenous lipid neurotransmitter with cannabinergic activity, binding both the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. | ||||
| GC42085 | 20-hydroxy N-Arachidonoyl Taurine | - | >95.00% | |
Arachidonic acid is metabolized by cytochrome P450 (CYP450) 4A ω-hydroxylase to 20-HETE, which acts as a vasoconstrictor in the kidney and brain. | ||||
